株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

薬物乱用検査市場(サンプルベース検査:現場および試験所における尿、唾液、毛髪の検査):世界の業界分析、規模、シェア、成長、動向および予測

Drugs of Abuse Testing Market (Sample Based Testing - Urine, Saliva and Hair Onsite and laboratory Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

発行 Transparency Market Research 商品コード 294620
出版日 ページ情報 英文 77 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
薬物乱用検査市場(サンプルベース検査:現場および試験所における尿、唾液、毛髪の検査):世界の業界分析、規模、シェア、成長、動向および予測 Drugs of Abuse Testing Market (Sample Based Testing - Urine, Saliva and Hair Onsite and laboratory Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018
出版日: 2014年01月28日 ページ情報: 英文 77 Pages
概要

世界の薬物乱用市場は、違法薬物の影響に対する政府および非政府機関の認識向上や、薬物乱用に伴う社会経済的損失の制御のため、急速に成長しています。違法薬物の世界的消費量の増加や組織レベルでの薬物乱用検査の導入、違法薬物の生産量増加、薬物乱用による死亡率および交通事故の増加などが、同市場の拡大を推進しています。

当レポートでは、世界の薬物乱用市場について調査し、市場の動向、市場規模と将来予測、地域別動向、競合環境などをまとめ、企業プロファイルとともに、概略下記の構成で取り上げております。

第1章 序論

第2章 エグゼクティブサマリー

第3章 薬物乱用検査市場:業界分析

  • イントロダクション
    • 国際的な薬物密売
    • 北米における違法薬物の不法取引と使用
    • 欧州における違法薬物の不法取引と使用
    • アジア太平洋地域における違法薬物の不法取引と使用
  • 市場促進因子
    • 世界的な違法薬物の消費量増加
    • 組織レベルでの乱用薬物検査の導入
    • 違法薬物の生産量と取引量増加
    • 薬物乱用による死亡率および交通事故の増加
  • 市場阻害因子
    • 違法薬物検査に伴う社会的懸念
    • 様々な薬物の法制化
    • 経済的変動と費用の問題

第4章 ポーターズファイブフォース分析

第5章 世界の薬物乱用検査市場

第6章 薬物乱用検査市場:試験技術分析

  • 免疫アッセイ
  • クロマトグラフィ

第7章 薬物乱用検査市場:サンプル分析

  • 試験所薬剤検査
  • 現場スクリーニング検査

第8章 単一対複数のパラメーター検査

第9章 薬物乱用検査市場:地域別セグメント分析

  • 北米の薬物検査シナリオ
  • 欧州の薬物検査シナリオ
  • アジア太平洋地域の薬物検査シナリオ

第10章 近年の発展

第11章 企業プロファイル

  • Roche Diagnostics
  • Quest Diagnostic
  • LabCorp (Laboratory Corporation of America)
  • Alere
  • Abbott Laboratories
  • Randox Laboratories
  • Psychemedics Corporation
  • Bio-Rad Laboratories
  • Sonic Healthcare
  • Thermo Fisher Scientific

図表

目次

The global drugs of abuse testing market is rapidly growing due to the rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. Globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse.is also supporting the growth of the drugs of abuse testing market.

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of XX% during 2013 - 2018. The other major samples for drugs of abuse testing are Saliva and Hair. This report forecasts future potential of all these drugs of abuse testing markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter's forces, competitive landscape and company profiles of key players.

The report categorizes the global drugs of abuse market based on their type and geography. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only. In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.

Table of Contents

Chapter 1 Preface 8

  • 1.1 Report Description 8
  • 1.2 Markets covered 8
  • 1.3 Research methodology 8

Chapter 2 Executive Summary 10

Chapter 3 Drugs of Abuse Testing Market - Industry Analysis 11

  • 3.1 Introduction 11
    • 3.1.1 International drug trafficking 12
    • 3.1.2 Drug trafficking and illicit drug use in North America 12
    • 3.1.3 Drug trafficking and illicit drug use in Europe 12
    • 3.1.4 Drug trafficking and illicit drug use in Asia-Pacific 13
  • 3.2 Market Drivers 14
    • 3.2.1 Globally rising consumption of illicit drugs 14
    • 3.2.2 Adoption of drugs of abuse (DOA) testing at organizational level 15
    • 3.2.3 Increased production of illicit drugs and their trade 16
    • 3.2.4 Increasing death rates/road accidents due to drug abuse 17
  • 3.3 Restraints 18
    • 3.3.1 Social concerns associated with illicit drugs testing 18
    • 3.3.2 Legalization of various drugs 18
    • 3.3.3 Economic volatility and cost concerns 19

Chapter 4 Porter's five force analysis 20

  • 4.1 Bargaining power of buyers 20
  • 4.2 Bargaining power of suppliers 21
  • 4.3 Threat from new entrants 21
  • 4.4 Intensity of rivalry 21
  • 4.5 Threat from substitutes 21

Chapter 5 Global Drugs of Abuse Testing Market 22

Chapter 6 Drugs of Abuse Testing Market - Testing Technology Analysis 24

  • 6.1 Immunoassay Technology 24
  • 6.2 Chromatography Technology 25

Chapter 7 Drugs of Abuse Testing Market - Sample Analysis 27

  • 7.1 Laboratory drug test 30
  • 7.2 On-site screening test 31

Chapter 8 Single vs. Multiple Parameter Test 33

Chapter 9 Drugs of Abuse Market - Regional Segment Analysis 35

  • 9.1 Scenario of drug testing in North America 35
    • 9.1.1 Scenario of drug testing in the US 37
  • 9.2 Scenario of drug testing in Europe 39
    • 9.2.1 Scenario of drug testing in the UK 41
    • 9.2.2 Scenario of drug testing in France 43
    • 9.2.3 Scenario of drug testing in Germany 44
  • 9.3 Scenario of drug testing in Asia-Pacific 46
    • 9.3.1 Scenario of drug testing in India 48
    • 9.3.2 Scenario of drug testing in China 50
    • 9.3.3 Scenario of drug testing in Japan 52

Chapter 10 Recent Developments 54

Chapter 11 Company profiles 57

  • 11.1 Roche Diagnostics 57
    • 11.1.1 Overview 57
    • 11.1.2 Products & Segments 57
    • 11.1.3 Financial Performance 58
  • 11.2 Quest Diagnostic 59
    • 11.2.1 Overview 59
    • 11.2.2 Products & Segments 59
    • 11.2.3 Financial Performance 60
  • 11.3 LabCorp (Laboratory Corporation of America) 61
    • 11.3.1 Overview 61
    • 11.3.2 Products & Segments 61
    • 11.3.3 Financial Performance 62
  • 11.4 Alere 63
    • 11.4.1 Overview 63
    • 11.4.2 Products and Segments 63
    • 11.4.3 Financial Performance 64
  • 11.5 Abbott Laboratories 65
    • 11.5.1 Overview 65
    • 11.5.2 Products & Segments 65
    • 11.5.3 Financial Performance 66
  • 11.6 Randox Laboratories 67
    • 11.6.1 Overview 67
    • 11.6.2 Products & Segments 67
    • 11.6.3 Financial Performance 67
  • 11.7 Psychemedics Corporation 68
    • 11.7.1 Overview 68
    • 11.7.2 Products & Services 68
    • 11.7.3 Financial Performance 69
  • 11.8 Bio-Rad Laboratories 70
    • 11.8.1 Overview 70
    • 11.8.2 Products & Segmentation 70
    • 11.8.3 Financial Performance 71
  • 11.9 Sonic Healthcare 72
    • 11.9.1 Overview 72
    • 11.9.2 Products & Services 72
    • 11.9.3 Financial Performance 73
  • 11.10 Thermo Fisher Scientific 74
    • 11.10.1 Overview 74
    • 11.10.2 Products & Segments 74
    • 11.10.3 Financial performance 75

List of Figures

  • FIG. 1 Global illicit drug users (in millions) 2009-2011 15
  • FIG. 2 Porter's five forces analysis for drugs of abuse testing market 20
  • FIG. 3 Drug abuse testing market strategic developments (2011-2013) 54
  • FIG. 4 Company revenues (USD million, 2011-2012) 58
  • FIG. 5 Company revenues (USD million, 2011 - 2012) 60
  • FIG. 6 Company revenues (USD million, 2011 - 2012) 62
  • FIG. 7 Company revenues (USD million, 2011 - 2012) 64
  • FIG. 8 Company revenues (USD million, 2011 - 2012) 66
  • FIG. 9 Company revenues (USD million, 2011 - 2012) 69
  • FIG. 10 Company revenues (USD million, 2011-2012) 71
  • FIG. 11 Company revenues (USD million, 2011-2012) 73
  • FIG. 12 Company revenues (USD million, 2011-2012) 75

List of Tables

  • TABLE 1 Illicit drug users in various parts of the world, by major drugs (% share, 2011) 11
  • TABLE 2 Drivers for drugs of abuse testing market: Impact analysis 14
  • TABLE 3 Restraints for drugs of abuse testing market: Impact analysis 18
  • TABLE 4 Global drugs of abuse testing market size, by geography 2008-2012 (USD million) 22
  • TABLE 5 Global drugs of abuse testing market size, by geography 2013-2018 (USD million) 22
  • TABLE 6 Some of the key market players offering drugs testing equipment and products 26
  • TABLE 7 Characteristics of different specimens for drug testing 28
  • TABLE 8 Global drugs of abuse testing market, by sample 2008-2012 (USD million) 29
  • TABLE 9 Global drugs of abuse testing market, by sample 2013-2018 (USD million) 29
  • TABLE 10 Advantage and disadvantage of laboratory drug screening test 30
  • TABLE 11 Advantage and disadvantage of on-site drug screening test 31
  • TABLE 12 Global drugs of abuse testing market, by test location 2008-2012 (USD million) 32
  • TABLE 13 Global drugs of abuse testing market, by test location 2013-2018 (USD million) 32
  • TABLE 14 Advantages of multi panel drug test over single paned drug test 33
  • TABLE 15 North American drugs of abuse testing market, by geography 2008-2012 (USD million) 35
  • TABLE 16 North American drugs of abuse testing market, by geography 2013-2018 (USD million) 36
  • TABLE 17 North American drugs of abuse testing market, by test location 2008-2012 (USD million) 36
  • TABLE 18 North American drugs of abuse testing market, by test location 2013-2018 (USD million) 37
  • TABLE 19 US drugs of abuse testing market, by test location 2008-2012 (USD million) 38
  • TABLE 20 US drugs of abuse testing market, by test location 2013-2018 (USD million) 38
  • TABLE 21 European drugs of abuse testing market, by geography 2008-2012 (USD million) 39
  • TABLE 22 European drugs of abuse testing market, by geography 2013-2018 (USD million) 40
  • TABLE 23 European drugs of abuse testing market, by test location 2008-2012 (USD million) 40
  • TABLE 24 European drugs of abuse testing market, by test location 2013-2018 (USD million) 41
  • TABLE 25 UK drugs of abuse testing market, by test location 2008-2012 (USD million) 42
  • TABLE 26 UK drugs of abuse testing market, by test location 2013-2018 (USD million) 42
  • TABLE 27 France drugs of abuse testing market, by test location 2008-2012 (USD million) 43
  • TABLE 28 France drugs of abuse testing market, by test location 2013-2018 (USD million) 44
  • TABLE 29 Germany drugs of abuse testing market, by test location 2008-2012 (USD million) 45
  • TABLE 30 Germany drugs of abuse testing market, by test location 2013-2018 (USD million) 45
  • TABLE 31 Asian drugs of abuse testing market, by geography 2008-2012 (USD million) 46
  • TABLE 32 Asian drugs of abuse testing market, by geography 2013-2018 (USD million) 47
  • TABLE 33 Asian drugs of abuse testing market, by test location 2008-2012 (USD million) 47
  • TABLE 34 Asian drugs of abuse testing market, by test location 2013-2018 (USD million) 48
  • TABLE 35 Indian drugs of abuse testing market, by test location 2008-2012 (USD thousand) 49
  • TABLE 36 Indian drugs of abuse testing market, by test location 2013-2018 (USD thousand) 49
  • TABLE 37 China drugs of abuse testing market, by test location 2008-2012 (USD thousand) 51
  • TABLE 38 China drugs of abuse testing market, by test location 2013-2018 (USD thousand) 51
  • TABLE 39 Japan drugs of abuse testing market, by test location 2008-2012 (USD million) 52
  • TABLE 40 Japan drugs of abuse testing market, by test location 2013-2018 (USD million) 53
  • TABLE 41 Major product launches in drugs of abuse testing market (2011-2013) 54
  • TABLE 42 Mergers and acquisitions in drugs of abuse testing market (2011-2013) 55
  • TABLE 43 Partnerships in drugs of abuse testing market (2011-2013) 56
Back to Top